Effective and evidence-based responses to the increased availability and use of synthetic drugs and stimulants in Europe
Overview
The Horizon Europe grant opportunity titled "Effective and evidence-based responses to the increased availability and use of synthetic drugs and stimulants in Europe" (HORIZON-CL3-2027-01-FCT-05) is now open for applications, with a planned opening date of May 5, 2027, and a deadline of November 4, 2027. The total budget for this topic is €8 million, which will fund two grants, each amounting to €4 million.
Eligible applicants include a diverse range of entities such as research institutions, universities, civil society organizations (CSOs), non-governmental organizations (NGOs), police authorities, and other public or private entities relevant to security research. Notably, the application must include at least three police authorities and two civil society organizations or NGOs from at least three different EU Member States or Associated Countries, emphasizing the need for a collaborative consortium.
The funding type is a grant structured as a lump sum, allowing a simplified budget management process that provides flexibility for the grantees while ensuring accountability for achieving specified outcomes. This grant is designed for projects at the demonstration and deployment stage, focusing on practical solutions to combat the rise in synthetic drug issues.
The geographical scope includes all EU Member States and Associated Countries, specifically covering the 27 EU Member States and EEA EFTA countries like Iceland, Liechtenstein, and Norway. The project is categorized under the security sector, aiming to enhance law enforcement and public health response capabilities through innovative technologies and methodologies.
Key areas of focus for funded projects include strengthening the evidence base for prevention and harm reduction strategies, developing tools to combat drug trafficking, analyzing the external factors influencing drug markets, and fostering collaboration between researchers and security practitioners. Participating organizations will benefit from monetary support and non-monetary services like access to the Europol Innovation Lab and coordination with the EU Drugs Agency.
The application process is single-stage, requiring complete proposals upfront without preliminary submissions. Success rates are not specifically detailed but are generally competitive, with an expectation of around 10-20% for similar Horizon Europe funding calls. While co-funding is not explicitly required, it is encouraged to enhance project credibility.
In summary, this grant aims to produce effective, evidence-based responses to the challenges posed by synthetic drugs and stimulants in Europe, emphasizing multi-disciplinary collaboration, scientific research, and practical implementation within the European context. The deadline for submissions is November 4, 2027.
Eligible applicants include a diverse range of entities such as research institutions, universities, civil society organizations (CSOs), non-governmental organizations (NGOs), police authorities, and other public or private entities relevant to security research. Notably, the application must include at least three police authorities and two civil society organizations or NGOs from at least three different EU Member States or Associated Countries, emphasizing the need for a collaborative consortium.
The funding type is a grant structured as a lump sum, allowing a simplified budget management process that provides flexibility for the grantees while ensuring accountability for achieving specified outcomes. This grant is designed for projects at the demonstration and deployment stage, focusing on practical solutions to combat the rise in synthetic drug issues.
The geographical scope includes all EU Member States and Associated Countries, specifically covering the 27 EU Member States and EEA EFTA countries like Iceland, Liechtenstein, and Norway. The project is categorized under the security sector, aiming to enhance law enforcement and public health response capabilities through innovative technologies and methodologies.
Key areas of focus for funded projects include strengthening the evidence base for prevention and harm reduction strategies, developing tools to combat drug trafficking, analyzing the external factors influencing drug markets, and fostering collaboration between researchers and security practitioners. Participating organizations will benefit from monetary support and non-monetary services like access to the Europol Innovation Lab and coordination with the EU Drugs Agency.
The application process is single-stage, requiring complete proposals upfront without preliminary submissions. Success rates are not specifically detailed but are generally competitive, with an expectation of around 10-20% for similar Horizon Europe funding calls. While co-funding is not explicitly required, it is encouraged to enhance project credibility.
In summary, this grant aims to produce effective, evidence-based responses to the challenges posed by synthetic drugs and stimulants in Europe, emphasizing multi-disciplinary collaboration, scientific research, and practical implementation within the European context. The deadline for submissions is November 4, 2027.
Detail
This EU funding opportunity, under the Horizon Europe program, aims to address the growing problem of synthetic drugs and stimulants, including cocaine and crack cocaine, within the EU. The call, titled "Effective and evidence-based responses to the increased availability and use of synthetic drugs and stimulants in Europe," seeks proposals that can develop effective strategies for prevention, treatment, and harm reduction.
The key expected outcomes of funded projects include:
Improved evidence base for prevention, treatment, and harm reduction related to synthetic drugs and stimulants.
Equipping European security practitioners, such as Police Authorities, Civil Society Organisations, and Non-Governmental Organisations, with the necessary skills, tools, and technology to reduce violence and offenses linked to these substances and to combat drug trafficking across the entire supply chain.
Enhanced understanding among security practitioners and policymakers regarding the impact of societal, technological, legal, economic, and ethical factors on the availability, use, and markets of synthetic drugs.
The scope of the projects should cover several key areas:
Evidence-based approaches: Strengthening the evidence base to inform effective prevention strategies, treatment modalities, and harm reduction practices. This includes identifying best practices and evaluating their efficacy.
Reducing violence and offending: Exploring strategies to mitigate violence and criminal behavior associated with synthetic drugs, understanding socio-economic and cultural factors, and proposing targeted interventions.
Improving technologies and tools: Developing technologies and tools to combat drug trafficking from its origin to destination across the entire supply chain.
External drivers of change: Analyzing the impact of geopolitical situations, legal frameworks, and societal factors on drug availability and consumption, and identifying adaptive response strategies.
Collaboration and Coordination:
Proposals should foster collaboration among researchers, policymakers, and security practitioners.
Coordination among successful proposals is encouraged to avoid duplication and maximize impact.
Active involvement and feedback from security practitioners are essential, with a mid-term deliverable planned to assess project outcomes.
Activities should address both technological and societal dimensions.
Engagement with the Europol Innovation Lab and the EU Drugs Agency is expected, including validating project outcomes.
Proposals should address considerations in the Introduction of the Fighting Crime and Terrorism Destination.
General Conditions:
Admissibility: Proposal page limits and layout must adhere to Annex A and Annex E of the Horizon Europe Work Programme General Annexes and Part B of the Application Form.
Eligible Countries: As described in Annex B of the Work Programme General Annexes. Some non-EU/non-Associated Countries have specific funding provisions; refer to the Horizon Europe Programme Guide.
Other Eligible Conditions:
Mandatory involvement of at least 3 Police Authorities and 2 Civil Society Organisations (or Non-Governmental Organisations) from at least 3 different EU Member States or Associated Countries. Applicants must provide information about these security practitioners in the application form.
If projects use satellite-based data, they must utilize Copernicus and/or Galileo/EGNOS.
Financial and Operational Capacity and Exclusion: As described in Annex C of the Work Programme General Annexes.
Evaluation and Award:
Award criteria, scoring, and thresholds are detailed in Annex D of the Work Programme General Annexes.
Submission and evaluation processes are described in Annex F of the Work Programme General Annexes and the Online Manual.
The indicative timeline for evaluation and grant agreement is described in Annex F of the Work Programme General Annexes.
Legal and Financial Set-Up:
The granting authority can object to ownership transfer or exclusive licensing of results for up to 4 years after the action's end, as per Annex 5.
Eligible costs will be in the form of a lump sum, as defined in the Decision of 7 July 2021.
Application and Evaluation Forms:
Application form templates are available in the Submission System.
Standard application forms are available for HE RIA, IA, CSA, RI, PCP, PPI, COFUND, FPA, MSCA PF, MSCA DN, MSCA SE, MSCA COFUND, MSCA COFUND CE, ERC STG, ERC COG, ERC ADG, ERC POC, ERC SYG, EIC PATHFINDER CHALLENGES, EIC PATHFINDER OPEN, EIC TRANSITION, EIC STEP, and EIC Accelerator (stage 1 and 2).
Evaluation form templates will be adapted as necessary.
Guidance and Additional Documents:
HE Programme Guide
Model Grant Agreements (MGA): HE MGA, HE Unit MGA, Lump Sum MGA, Operating Grants MGA, Framework Partnership Agreement FPA
Call-specific instructions
Detailed budget table (HE LS)
Information on financial support to third parties (HE)
Information on clinical studies (HE)
Guidance: "Lump sums - what do I need to know?"
HE Main Work Programme 2025 – 1. General Introduction
HE Main Work Programme 2023–2025 – 2. Marie Skłodowska-Curie Actions
HE Main Work Programme 2025 – 3. Research Infrastructures
HE Main Work Programme 2025 – 4. Health
HE Main Work Programme 2025 – 5. Culture, creativity and inclusive society
HE Main Work Programme 2025 – 6. Civil Security for Society
HE Main Work Programme 2025 – 7. Digital, Industry and Space
HE Main Work Programme 2025 – 8. Climate, Energy and Mobility
HE Main Work Programme 2025 – 9. Food, Bioeconomy, Natural Resources, Agriculture and Environment
HE Main Work Programme 2025 – 10. European Innovation Ecosystems (EIE)
HE Main Work Programme 2025 – 11. Widening participation and strengthening the European Research Area
HE Main Work Programme 2025 – 12. Missions
HE Main Work Programme 2025 – 13. New European Bauhaus Facility (NEB)
HE Main Work Programme 2025 – 14. General Annexes
HE Main Work Programme 2023–2025 – 13. General Annexes
EIC Work Programme 2025
ERC Work Programme 2026
HE Programme Guide
HE Framework Programme 2021/695
HE Specific Programme Decision 2021/764
EU Financial Regulation 2024/2509
Decision authorising the use of lump sum contributions under the Horizon Europe Programme
Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment
EU Grants AGA — Annotated Model Grant Agreement
Funding & Tenders Portal Online Manual
Funding & Tenders Portal Terms and Conditions
Funding & Tenders Portal Privacy Statement
Budget Overview:
The call includes several topics with varying budgets and action types (RIA, IA, CSA, PCP). The opening date for submissions is planned for 05 May 2027, with a deadline of 04 November 2027.
The indicative number of grants and contributions for each topic are as follows:
HORIZON-CL3-2027-01-BM-01 (RIA): Budget 8,000,000 EUR, Contribution around 4,000,000 EUR, 2 grants
HORIZON-CL3-2027-01-BM-02 (RIA): Budget 8,000,000 EUR, Contribution around 4,000,000 EUR, 2 grants
HORIZON-CL3-2027-01-BM-03 (RIA): Budget 14,000,000 EUR, Contribution around 3,500,000 EUR, 4 grants
HORIZON-CL3-2027-01-DRS-01 (IA): Budget 7,670,000 EUR, Contribution around 3,835,000 EUR, 2 grants
HORIZON-CL3-2027-01-DRS-02 (RIA): Budget 6,000,000 EUR, Contribution around 3,000,000 EUR, 2 grants
HORIZON-CL3-2027-01-DRS-03 (IA): Budget 9,000,000 EUR, Contribution around 3,000,000 EUR, 3 grants
HORIZON-CL3-2027-01-DRS-04 (IA): Budget 8,000,000 EUR, Contribution around 4,000,000 EUR, 2 grants
HORIZON-CL3-2027-01-FCT-01 (IA): Budget 7,833,000 EUR, Contribution around 7,833,000 EUR, 1 grant
HORIZON-CL3-2027-01-FCT-02 (IA): Budget 6,000,000 EUR, Contribution around 3,000,000 EUR, 2 grants
HORIZON-CL3-2027-01-FCT-03 (RIA): Budget 6,000,000 EUR, Contribution around 3,000,000 EUR, 2 grants
HORIZON-CL3-2027-01-FCT-04 (IA): Budget 9,000,000 EUR, Contribution around 4,500,000 EUR, 2 grants
HORIZON-CL3-2027-01-FCT-05 (IA): Budget 8,000,000 EUR, Contribution around 4,000,000 EUR, 2 grants
HORIZON-CL3-2027-01-INFRA-01 (IA): Budget 12,000,000 EUR, Contribution around 6,000,000 EUR, 2 grants
HORIZON-CL3-2027-01-INFRA-02 (IA): Budget 7,670,000 EUR, Contribution around 3,835,000 EUR, 2 grants
HORIZON-CL3-2027-01-SSRI-01 (IA): Budget 4,500,000 EUR, Contribution around 1,500,000 EUR, 3 grants
HORIZON-CL3-2027-01-SSRI-02 (CSA): Budget 2,000,000 EUR, Contribution around 1,000,000 EUR, 2 grants
HORIZON-CL3-2027-01-SSRI-03 (PCP): Budget 5,830,000 EUR, Contribution around 5,830,000 EUR, 1 grant
Partner Search:
The Funding & Tenders Portal allows LEARs, Account Administrators, and self-registrants to publish partner requests for open and forthcoming topics.
This Horizon Europe call is focused on developing innovative and evidence-based strategies to combat the increasing availability and use of synthetic drugs and stimulants within the EU. It seeks to improve prevention, treatment, and harm reduction efforts by fostering collaboration among researchers, policymakers, and security practitioners. The call emphasizes the need for a comprehensive approach that addresses both the technological and societal dimensions of the drug problem, with a strong focus on practical outcomes and the involvement of key European agencies like Europol and the EU Drugs Agency. The funding is provided as a lump sum, and the call requires the active participation of Police Authorities and Civil Society Organisations, making it a collaborative effort to enhance civil security across Europe.
The key expected outcomes of funded projects include:
Improved evidence base for prevention, treatment, and harm reduction related to synthetic drugs and stimulants.
Equipping European security practitioners, such as Police Authorities, Civil Society Organisations, and Non-Governmental Organisations, with the necessary skills, tools, and technology to reduce violence and offenses linked to these substances and to combat drug trafficking across the entire supply chain.
Enhanced understanding among security practitioners and policymakers regarding the impact of societal, technological, legal, economic, and ethical factors on the availability, use, and markets of synthetic drugs.
The scope of the projects should cover several key areas:
Evidence-based approaches: Strengthening the evidence base to inform effective prevention strategies, treatment modalities, and harm reduction practices. This includes identifying best practices and evaluating their efficacy.
Reducing violence and offending: Exploring strategies to mitigate violence and criminal behavior associated with synthetic drugs, understanding socio-economic and cultural factors, and proposing targeted interventions.
Improving technologies and tools: Developing technologies and tools to combat drug trafficking from its origin to destination across the entire supply chain.
External drivers of change: Analyzing the impact of geopolitical situations, legal frameworks, and societal factors on drug availability and consumption, and identifying adaptive response strategies.
Collaboration and Coordination:
Proposals should foster collaboration among researchers, policymakers, and security practitioners.
Coordination among successful proposals is encouraged to avoid duplication and maximize impact.
Active involvement and feedback from security practitioners are essential, with a mid-term deliverable planned to assess project outcomes.
Activities should address both technological and societal dimensions.
Engagement with the Europol Innovation Lab and the EU Drugs Agency is expected, including validating project outcomes.
Proposals should address considerations in the Introduction of the Fighting Crime and Terrorism Destination.
General Conditions:
Admissibility: Proposal page limits and layout must adhere to Annex A and Annex E of the Horizon Europe Work Programme General Annexes and Part B of the Application Form.
Eligible Countries: As described in Annex B of the Work Programme General Annexes. Some non-EU/non-Associated Countries have specific funding provisions; refer to the Horizon Europe Programme Guide.
Other Eligible Conditions:
Mandatory involvement of at least 3 Police Authorities and 2 Civil Society Organisations (or Non-Governmental Organisations) from at least 3 different EU Member States or Associated Countries. Applicants must provide information about these security practitioners in the application form.
If projects use satellite-based data, they must utilize Copernicus and/or Galileo/EGNOS.
Financial and Operational Capacity and Exclusion: As described in Annex C of the Work Programme General Annexes.
Evaluation and Award:
Award criteria, scoring, and thresholds are detailed in Annex D of the Work Programme General Annexes.
Submission and evaluation processes are described in Annex F of the Work Programme General Annexes and the Online Manual.
The indicative timeline for evaluation and grant agreement is described in Annex F of the Work Programme General Annexes.
Legal and Financial Set-Up:
The granting authority can object to ownership transfer or exclusive licensing of results for up to 4 years after the action's end, as per Annex 5.
Eligible costs will be in the form of a lump sum, as defined in the Decision of 7 July 2021.
Application and Evaluation Forms:
Application form templates are available in the Submission System.
Standard application forms are available for HE RIA, IA, CSA, RI, PCP, PPI, COFUND, FPA, MSCA PF, MSCA DN, MSCA SE, MSCA COFUND, MSCA COFUND CE, ERC STG, ERC COG, ERC ADG, ERC POC, ERC SYG, EIC PATHFINDER CHALLENGES, EIC PATHFINDER OPEN, EIC TRANSITION, EIC STEP, and EIC Accelerator (stage 1 and 2).
Evaluation form templates will be adapted as necessary.
Guidance and Additional Documents:
HE Programme Guide
Model Grant Agreements (MGA): HE MGA, HE Unit MGA, Lump Sum MGA, Operating Grants MGA, Framework Partnership Agreement FPA
Call-specific instructions
Detailed budget table (HE LS)
Information on financial support to third parties (HE)
Information on clinical studies (HE)
Guidance: "Lump sums - what do I need to know?"
HE Main Work Programme 2025 – 1. General Introduction
HE Main Work Programme 2023–2025 – 2. Marie Skłodowska-Curie Actions
HE Main Work Programme 2025 – 3. Research Infrastructures
HE Main Work Programme 2025 – 4. Health
HE Main Work Programme 2025 – 5. Culture, creativity and inclusive society
HE Main Work Programme 2025 – 6. Civil Security for Society
HE Main Work Programme 2025 – 7. Digital, Industry and Space
HE Main Work Programme 2025 – 8. Climate, Energy and Mobility
HE Main Work Programme 2025 – 9. Food, Bioeconomy, Natural Resources, Agriculture and Environment
HE Main Work Programme 2025 – 10. European Innovation Ecosystems (EIE)
HE Main Work Programme 2025 – 11. Widening participation and strengthening the European Research Area
HE Main Work Programme 2025 – 12. Missions
HE Main Work Programme 2025 – 13. New European Bauhaus Facility (NEB)
HE Main Work Programme 2025 – 14. General Annexes
HE Main Work Programme 2023–2025 – 13. General Annexes
EIC Work Programme 2025
ERC Work Programme 2026
HE Programme Guide
HE Framework Programme 2021/695
HE Specific Programme Decision 2021/764
EU Financial Regulation 2024/2509
Decision authorising the use of lump sum contributions under the Horizon Europe Programme
Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment
EU Grants AGA — Annotated Model Grant Agreement
Funding & Tenders Portal Online Manual
Funding & Tenders Portal Terms and Conditions
Funding & Tenders Portal Privacy Statement
Budget Overview:
The call includes several topics with varying budgets and action types (RIA, IA, CSA, PCP). The opening date for submissions is planned for 05 May 2027, with a deadline of 04 November 2027.
The indicative number of grants and contributions for each topic are as follows:
HORIZON-CL3-2027-01-BM-01 (RIA): Budget 8,000,000 EUR, Contribution around 4,000,000 EUR, 2 grants
HORIZON-CL3-2027-01-BM-02 (RIA): Budget 8,000,000 EUR, Contribution around 4,000,000 EUR, 2 grants
HORIZON-CL3-2027-01-BM-03 (RIA): Budget 14,000,000 EUR, Contribution around 3,500,000 EUR, 4 grants
HORIZON-CL3-2027-01-DRS-01 (IA): Budget 7,670,000 EUR, Contribution around 3,835,000 EUR, 2 grants
HORIZON-CL3-2027-01-DRS-02 (RIA): Budget 6,000,000 EUR, Contribution around 3,000,000 EUR, 2 grants
HORIZON-CL3-2027-01-DRS-03 (IA): Budget 9,000,000 EUR, Contribution around 3,000,000 EUR, 3 grants
HORIZON-CL3-2027-01-DRS-04 (IA): Budget 8,000,000 EUR, Contribution around 4,000,000 EUR, 2 grants
HORIZON-CL3-2027-01-FCT-01 (IA): Budget 7,833,000 EUR, Contribution around 7,833,000 EUR, 1 grant
HORIZON-CL3-2027-01-FCT-02 (IA): Budget 6,000,000 EUR, Contribution around 3,000,000 EUR, 2 grants
HORIZON-CL3-2027-01-FCT-03 (RIA): Budget 6,000,000 EUR, Contribution around 3,000,000 EUR, 2 grants
HORIZON-CL3-2027-01-FCT-04 (IA): Budget 9,000,000 EUR, Contribution around 4,500,000 EUR, 2 grants
HORIZON-CL3-2027-01-FCT-05 (IA): Budget 8,000,000 EUR, Contribution around 4,000,000 EUR, 2 grants
HORIZON-CL3-2027-01-INFRA-01 (IA): Budget 12,000,000 EUR, Contribution around 6,000,000 EUR, 2 grants
HORIZON-CL3-2027-01-INFRA-02 (IA): Budget 7,670,000 EUR, Contribution around 3,835,000 EUR, 2 grants
HORIZON-CL3-2027-01-SSRI-01 (IA): Budget 4,500,000 EUR, Contribution around 1,500,000 EUR, 3 grants
HORIZON-CL3-2027-01-SSRI-02 (CSA): Budget 2,000,000 EUR, Contribution around 1,000,000 EUR, 2 grants
HORIZON-CL3-2027-01-SSRI-03 (PCP): Budget 5,830,000 EUR, Contribution around 5,830,000 EUR, 1 grant
Partner Search:
The Funding & Tenders Portal allows LEARs, Account Administrators, and self-registrants to publish partner requests for open and forthcoming topics.
This Horizon Europe call is focused on developing innovative and evidence-based strategies to combat the increasing availability and use of synthetic drugs and stimulants within the EU. It seeks to improve prevention, treatment, and harm reduction efforts by fostering collaboration among researchers, policymakers, and security practitioners. The call emphasizes the need for a comprehensive approach that addresses both the technological and societal dimensions of the drug problem, with a strong focus on practical outcomes and the involvement of key European agencies like Europol and the EU Drugs Agency. The funding is provided as a lump sum, and the call requires the active participation of Police Authorities and Civil Society Organisations, making it a collaborative effort to enhance civil security across Europe.
Find a Consultant to Support You
Breakdown
Eligible Applicant Types: The eligible applicant types include Police Authorities and Civil Society Organisations (or Non-Governmental Organisations). While not explicitly stated, the general conditions refer to Annex B of the Work Programme General Annexes, which likely contains further details on eligible countries and, by extension, eligible applicant types. Based on the Horizon Europe framework, universities, research institutes, SMEs, and other organizations are likely eligible, provided they meet the specific requirements outlined for Police Authorities and Civil Society Organizations.
Funding Type: The funding type is primarily grant-based, utilizing HORIZON Innovation Actions (HORIZON-IA), HORIZON Research and Innovation Actions (HORIZON-RIA), HORIZON Coordination and Support Actions (HORIZON-CSA) and HORIZON Pre-commercial Procurement (HORIZON-PCP). The eligible costs will take the form of a lump sum as defined in the Decision of 7 July 2021 authorising the use of lump sum contributions under the Horizon Europe Programme.
Consortium Requirement: The opportunity requires a consortium. Specifically, it mandates the active involvement, as beneficiaries, of at least 3 Police Authorities and at least 2 Civil Society Organisations (or Non-Governmental Organisations) from at least 3 different EU Member States or Associated Countries.
Beneficiary Scope (Geographic Eligibility): The geographic eligibility includes EU Member States and Associated Countries. A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects.
Target Sector: The target sector is Civil Security for Society, with a specific focus on fighting crime and terrorism, particularly related to synthetic drugs and stimulants. This encompasses aspects of health (treatment and harm reduction), security/cybersecurity (combating drug trafficking), and innovation (development of new tools and technologies).
Mentioned Countries: The opportunity explicitly mentions EU Member States and Associated Countries. It also refers to non-EU/non-Associated Countries that may have specific provisions for funding participants in Horizon Europe projects.
Project Stage: The project stage varies depending on the specific action type. HORIZON-RIA actions typically focus on research and development, suggesting projects in the research, development, and validation stages. HORIZON-IA actions focus on innovation, indicating projects in the demonstration, commercialization, and scale-up stages. HORIZON-CSA actions support coordination and networking. HORIZON-PCP actions support pre-commercial procurement.
Funding Amount: The funding amount varies depending on the specific topic within the call, ranging from €2,000,000 to €14,000,000. The indicative number of grants per topic also varies, generally ranging from 1 to 4.
HORIZON-CL3-2027-01-BM-01 - HORIZON-RIA: €8,000,000 (around €4,000,000 per grant, 2 grants)
HORIZON-CL3-2027-01-BM-02 - HORIZON-RIA: €8,000,000 (around €4,000,000 per grant, 2 grants)
HORIZON-CL3-2027-01-BM-03 - HORIZON-RIA: €14,000,000 (around €3,500,000 per grant, 4 grants)
HORIZON-CL3-2027-01-DRS-01 - HORIZON-IA: €7,670,000 (around €3,835,000 per grant, 2 grants)
HORIZON-CL3-2027-01-DRS-02 - HORIZON-RIA: €6,000,000 (around €3,000,000 per grant, 2 grants)
HORIZON-CL3-2027-01-DRS-03 - HORIZON-IA: €9,000,000 (around €3,000,000 per grant, 3 grants)
HORIZON-CL3-2027-01-DRS-04 - HORIZON-IA: €8,000,000 (around €4,000,000 per grant, 2 grants)
HORIZON-CL3-2027-01-FCT-01 - HORIZON-IA: €7,833,000 (around €7,833,000 per grant, 1 grant)
HORIZON-CL3-2027-01-FCT-02 - HORIZON-IA: €6,000,000 (around €3,000,000 per grant, 2 grants)
HORIZON-CL3-2027-01-FCT-03 - HORIZON-RIA: €6,000,000 (around €3,000,000 per grant, 2 grants)
HORIZON-CL3-2027-01-FCT-04 - HORIZON-IA: €9,000,000 (around €4,500,000 per grant, 2 grants)
HORIZON-CL3-2027-01-FCT-05 - HORIZON-IA: €8,000,000 (around €4,000,000 per grant, 2 grants)
HORIZON-CL3-2027-01-INFRA-01 - HORIZON-IA: €12,000,000 (around €6,000,000 per grant, 2 grants)
HORIZON-CL3-2027-01-INFRA-02 - HORIZON-IA: €7,670,000 (around €3,835,000 per grant, 2 grants)
HORIZON-CL3-2027-01-SSRI-01 - HORIZON-IA: €4,500,000 (around €1,500,000 per grant, 3 grants)
HORIZON-CL3-2027-01-SSRI-02 - HORIZON-CSA: €2,000,000 (around €1,000,000 per grant, 2 grants)
HORIZON-CL3-2027-01-SSRI-03 - HORIZON-PCP: €5,830,000 (around €5,830,000 per grant, 1 grant)
Application Type: The application type is an open call with a single-stage submission process.
Nature of Support: The beneficiaries will receive money in the form of a lump sum grant.
Application Stages: The application process is a single-stage process.
Success Rates: The success rates are not explicitly mentioned, but the indicative number of grants per topic provides some insight. Given the competitive nature of Horizon Europe, success rates are likely to be in the 10 to 39% range or lower.
Co-funding Requirement: The information does not explicitly state a co-funding requirement. However, Horizon Europe often encourages or requires some level of co-funding, which might be detailed in the General Annexes or the specific topic description within the Work Programme.
Summary: This Horizon Europe call, under the Civil Security for Society destination, seeks proposals for innovation actions, research and innovation actions, coordination and support actions and pre-commercial procurement focused on developing effective and evidence-based responses to the increasing availability and use of synthetic drugs and stimulants within the EU. The call emphasizes the need for collaboration among researchers, policymakers, and security practitioners, particularly Police Authorities and Civil Society Organisations. Projects should aim to improve the evidence base for prevention, treatment, and harm reduction, equip security practitioners with relevant skills and tools, and enhance understanding of the external drivers influencing drug markets. The funding is provided as a lump sum, and the geographic scope includes EU Member States and Associated Countries. The call encompasses various project stages, from research and development to demonstration and scale-up, depending on the specific action type.
Funding Type: The funding type is primarily grant-based, utilizing HORIZON Innovation Actions (HORIZON-IA), HORIZON Research and Innovation Actions (HORIZON-RIA), HORIZON Coordination and Support Actions (HORIZON-CSA) and HORIZON Pre-commercial Procurement (HORIZON-PCP). The eligible costs will take the form of a lump sum as defined in the Decision of 7 July 2021 authorising the use of lump sum contributions under the Horizon Europe Programme.
Consortium Requirement: The opportunity requires a consortium. Specifically, it mandates the active involvement, as beneficiaries, of at least 3 Police Authorities and at least 2 Civil Society Organisations (or Non-Governmental Organisations) from at least 3 different EU Member States or Associated Countries.
Beneficiary Scope (Geographic Eligibility): The geographic eligibility includes EU Member States and Associated Countries. A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects.
Target Sector: The target sector is Civil Security for Society, with a specific focus on fighting crime and terrorism, particularly related to synthetic drugs and stimulants. This encompasses aspects of health (treatment and harm reduction), security/cybersecurity (combating drug trafficking), and innovation (development of new tools and technologies).
Mentioned Countries: The opportunity explicitly mentions EU Member States and Associated Countries. It also refers to non-EU/non-Associated Countries that may have specific provisions for funding participants in Horizon Europe projects.
Project Stage: The project stage varies depending on the specific action type. HORIZON-RIA actions typically focus on research and development, suggesting projects in the research, development, and validation stages. HORIZON-IA actions focus on innovation, indicating projects in the demonstration, commercialization, and scale-up stages. HORIZON-CSA actions support coordination and networking. HORIZON-PCP actions support pre-commercial procurement.
Funding Amount: The funding amount varies depending on the specific topic within the call, ranging from €2,000,000 to €14,000,000. The indicative number of grants per topic also varies, generally ranging from 1 to 4.
HORIZON-CL3-2027-01-BM-01 - HORIZON-RIA: €8,000,000 (around €4,000,000 per grant, 2 grants)
HORIZON-CL3-2027-01-BM-02 - HORIZON-RIA: €8,000,000 (around €4,000,000 per grant, 2 grants)
HORIZON-CL3-2027-01-BM-03 - HORIZON-RIA: €14,000,000 (around €3,500,000 per grant, 4 grants)
HORIZON-CL3-2027-01-DRS-01 - HORIZON-IA: €7,670,000 (around €3,835,000 per grant, 2 grants)
HORIZON-CL3-2027-01-DRS-02 - HORIZON-RIA: €6,000,000 (around €3,000,000 per grant, 2 grants)
HORIZON-CL3-2027-01-DRS-03 - HORIZON-IA: €9,000,000 (around €3,000,000 per grant, 3 grants)
HORIZON-CL3-2027-01-DRS-04 - HORIZON-IA: €8,000,000 (around €4,000,000 per grant, 2 grants)
HORIZON-CL3-2027-01-FCT-01 - HORIZON-IA: €7,833,000 (around €7,833,000 per grant, 1 grant)
HORIZON-CL3-2027-01-FCT-02 - HORIZON-IA: €6,000,000 (around €3,000,000 per grant, 2 grants)
HORIZON-CL3-2027-01-FCT-03 - HORIZON-RIA: €6,000,000 (around €3,000,000 per grant, 2 grants)
HORIZON-CL3-2027-01-FCT-04 - HORIZON-IA: €9,000,000 (around €4,500,000 per grant, 2 grants)
HORIZON-CL3-2027-01-FCT-05 - HORIZON-IA: €8,000,000 (around €4,000,000 per grant, 2 grants)
HORIZON-CL3-2027-01-INFRA-01 - HORIZON-IA: €12,000,000 (around €6,000,000 per grant, 2 grants)
HORIZON-CL3-2027-01-INFRA-02 - HORIZON-IA: €7,670,000 (around €3,835,000 per grant, 2 grants)
HORIZON-CL3-2027-01-SSRI-01 - HORIZON-IA: €4,500,000 (around €1,500,000 per grant, 3 grants)
HORIZON-CL3-2027-01-SSRI-02 - HORIZON-CSA: €2,000,000 (around €1,000,000 per grant, 2 grants)
HORIZON-CL3-2027-01-SSRI-03 - HORIZON-PCP: €5,830,000 (around €5,830,000 per grant, 1 grant)
Application Type: The application type is an open call with a single-stage submission process.
Nature of Support: The beneficiaries will receive money in the form of a lump sum grant.
Application Stages: The application process is a single-stage process.
Success Rates: The success rates are not explicitly mentioned, but the indicative number of grants per topic provides some insight. Given the competitive nature of Horizon Europe, success rates are likely to be in the 10 to 39% range or lower.
Co-funding Requirement: The information does not explicitly state a co-funding requirement. However, Horizon Europe often encourages or requires some level of co-funding, which might be detailed in the General Annexes or the specific topic description within the Work Programme.
Summary: This Horizon Europe call, under the Civil Security for Society destination, seeks proposals for innovation actions, research and innovation actions, coordination and support actions and pre-commercial procurement focused on developing effective and evidence-based responses to the increasing availability and use of synthetic drugs and stimulants within the EU. The call emphasizes the need for collaboration among researchers, policymakers, and security practitioners, particularly Police Authorities and Civil Society Organisations. Projects should aim to improve the evidence base for prevention, treatment, and harm reduction, equip security practitioners with relevant skills and tools, and enhance understanding of the external drivers influencing drug markets. The funding is provided as a lump sum, and the geographic scope includes EU Member States and Associated Countries. The call encompasses various project stages, from research and development to demonstration and scale-up, depending on the specific action type.
Short Summary
Impact Develop effective and evidence-based responses to the increased availability and use of synthetic drugs and stimulants in Europe, improving prevention, treatment, and harm reduction efforts. | Impact | Develop effective and evidence-based responses to the increased availability and use of synthetic drugs and stimulants in Europe, improving prevention, treatment, and harm reduction efforts. |
Applicant Applicants should possess skills in research, security practices, civil society engagement, and collaboration with law enforcement agencies. | Applicant | Applicants should possess skills in research, security practices, civil society engagement, and collaboration with law enforcement agencies. |
Developments Funding will support projects focused on civil security, law enforcement, drug policy, and innovative technologies to combat drug trafficking and associated violence. | Developments | Funding will support projects focused on civil security, law enforcement, drug policy, and innovative technologies to combat drug trafficking and associated violence. |
Applicant Type This funding is designed for research institutions, universities, civil society organizations, NGOs, police authorities, and other public or private entities engaged in security research. | Applicant Type | This funding is designed for research institutions, universities, civil society organizations, NGOs, police authorities, and other public or private entities engaged in security research. |
Consortium A consortium is required, including at least 3 Police Authorities and at least 2 Civil Society Organisations or NGOs from at least 3 different EU Member States or Associated Countries. | Consortium | A consortium is required, including at least 3 Police Authorities and at least 2 Civil Society Organisations or NGOs from at least 3 different EU Member States or Associated Countries. |
Funding Amount The total budget for this topic is €8,000,000, with approximately 2 grants of €4,000,000 each. | Funding Amount | The total budget for this topic is €8,000,000, with approximately 2 grants of €4,000,000 each. |
Countries Eligible countries include all EU Member States and Associated Countries, specifically EEA EFTA countries (Iceland, Liechtenstein, and Norway). | Countries | Eligible countries include all EU Member States and Associated Countries, specifically EEA EFTA countries (Iceland, Liechtenstein, and Norway). |
Industry The funding targets the civil security sector, focusing on law enforcement, drug policy, and public health. | Industry | The funding targets the civil security sector, focusing on law enforcement, drug policy, and public health. |
Update Log
No updates recorded yet.
Discover with AI
Let our intelligent agent help you find the perfect funding opportunities tailored to your needs.
Try AI Agent →
EU Grant Database
Explore European funding opportunities in our comprehensive, up-to-date collection.
Browse Database →
Stay Informed
Get notified when grants change, deadlines approach, or new opportunities match your interests.
Configure Notifications →
Track Your Favorites
Follow grants you're interested in and keep them organized in one place. Get updates on changes and deadlines.
Use the Follow button above ↑
Online harms detection and investigation tools using a short development cycle model
Call for ProposalForthcoming
The Horizon Europe call, specifically under the Civil Security for Society 2027 program, focuses on developing online harms detection and investigation tools. This initiative is structured as a...
November 4th, 2027
Prevention and mitigation of misuse of synthetic biology for bioterrorism purposes
Call for ProposalForthcoming
The European Union's grant opportunity, titled HORIZON-CL3-2026-01-FCT-06, focuses on the prevention and mitigation of the misuse of synthetic biology for bioterrorism purposes. It is part of the...
November 5th, 2026
Risk Assessments in Northern Eu
Call for ProposalOpen
The European Food Safety Authority (EFSA) has announced a call for proposals titled "Joint programming for risk assessments in vector-borne diseases" under the EU Bodies and Agencies (EUBA) program,...
February 4th, 2026
Risk Assessments in Southern Eu
Call for ProposalOpen
The European Food Safety Authority (EFSA) is offering a grant opportunity titled "Joint programming for risk assessments in vector-borne diseases" under identifier EUBA-EFSA-2025-BIOHAW-04-02-Lot2....
February 4th, 2026
Risk Assessment in Western Eu
Call for ProposalOpen
The European Food Safety Authority (EFSA) is initiating a call for proposals titled “Joint programming for risk assessments in vector-borne diseases” under the EU Bodies and Agencies (EUBA)...
February 4th, 2026
Strengthening plant health: addressing emerging plant pest risks
Call for ProposalForthcoming
The grant opportunity under Horizon Europe, titled HORIZON-CL6-2027-02-FARM2FORK-01-two-stage, focuses on strengthening plant health by addressing emerging plant pest risks. The total budget for this...
April 8th, 2027
Strengthening the EU plant protection ecosystem for a future-proof agriculture
Call for ProposalForthcoming
The Horizon Europe call titled "Strengthening the EU plant protection ecosystem for a future-proof agriculture" (HORIZON-CL6-2026-02-FARM2FORK-07) offers a funding opportunity through a Coordination...
April 14th, 2026
Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
Call for ProposalForthcoming
The EU funding opportunity HORIZON-HLTH-2026-01-DISEASE-02 focuses on innovative interventions to mitigate the harmful effects of digital technologies on the mental health of children and young...
April 16th, 2026
Risk Assessment in Eastern Eu
Call for ProposalOpen
The European Food Safety Authority (EFSA) has announced a funding opportunity under the EU Bodies and Agencies program, titled "Joint programming for risk assessments in vector-borne diseases"...
February 4th, 2026
Scaling and deploying innovations in migration management
Call for ProposalForthcoming
The EU funding opportunity HORIZON-CL2-2027-01-TRANSFO-08 focuses on scaling and deploying innovations in migration management within the framework of the Horizon Europe Programme. This initiative...
September 23rd, 2027
Strengthening evidence-based policies for the resilience of European agriculture and forestry and related supply chains against crises and systemic risks
Call for ProposalForthcoming
The HORIZON-CL6-2027-02-CLIMATE-02 grant opportunity, part of the Horizon Europe program, aims to enhance the resilience of European agriculture and forestry, along with their associated supply...
September 23rd, 2027
Closing the learning gap: uncovering causes and effective policy interventions for declining youth skills in mathematics, reading, and science
Call for ProposalForthcoming
The Horizon Europe grant opportunity HORIZON-CL2-2027-01-TRANSFO-06 focuses on "Closing the learning gap: uncovering causes and effective policy interventions for declining youth skills in...
September 23rd, 2027